Developing Accessible mHealth Programs for Depression Management in Bolivia
NCT ID: NCT02765542
Last Updated: 2016-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2014-07-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Automated Telephone System to Improve Treatment Adherence in People With Depression
NCT00136240
Telemonitoring Enhanced Support for Depression Self Management
NCT01834534
Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression
NCT02742064
Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
NCT03678194
Noninvasive Physiologic Sensors to Assess Depression
NCT02568865
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the event that the patient reports a health or self-care problem during their call (i.e., the patient reports rarely or never taking their medication), a report will automatically be generated and sent by email to the research team plus the patient's designated clinician so that follow-up can take place. The secure email address will be verified with each clinician, and be password protected.
The intervention will last up to 12 weeks, after which the patient will have a follow-up meeting with the research team and will complete a survey about the program. All follow-ups will take place either in person or over the phone.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Automated phone calls
Automated disease assessment \& self-care support phone calls for up to 12 weeks.
Automated disease assessment & self-care support phone calls
Automated disease assessment \& self-care support phone calls for up to 12 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Automated disease assessment & self-care support phone calls
Automated disease assessment \& self-care support phone calls for up to 12 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* PHQ-8 score of 10 or higher
Exclusion Criteria
* Prior inpatient psychiatric treatment
* Patients with probable bipolar disorder or cognitive impairment as indicated on validated screeners
21 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John Piette
VA Senior Research Career Scientist, Professor of Health Behavior and Health Education and of Internal Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John D Piette, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
El Servicio Departmental de Salud (SEDES) affiliated clinics
La Paz, , Bolivia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00087937
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.